D&B Business Directory
Outcome Sciences, Inc.
Overview
Outcome
Even after drug developers send their offspring out into the world, they still can't cut the apron-strings altogether. A provider of post-approval data management software, Outcome Sciences keeps the strings intact for pharmaceutical companies once their drugs have received regulatory approval and gone on to market or Phase IV testing. Outcome provides software that follows the drugs into the medical market where they are prescribed. Its Outcome-branded ...
Read More
applications enable Web-based data collection about patients reactions to the drugs, as well as online surveys of medical practitioners and study participants. Biopharmaceutical services company Quintiles bought the company in 2011.
Read Less
Richard Gliklich   See more contacts
?
?
Actual

?
Actual
#
Modelled
? ?
Contacts
Get in Touch with 8 Principals* and 2 Contacts
  • Richard Gliklich
    President and Chief Executive Officer
  • Contact 2
    ?
  • Contact 3
    ?
  • Contact 4
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings